Keywords: talima, raises, 19m, series, funding, round, site-specific

Talima raises $19M in series B funding round

Article | 04 June 2007

Site-specific US drug delivery company Talima Therapeutics has raised $19.0 million in an oversubscribed second funding round. This will allow the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Lamisil

Terbinafine

Nystatin

Go to drug listing